Julia Wertley-Rotenberry

Julia Wertley-Rotenberry serves as a Contracting Officer for the W6QK Acc-apg Durham under the Department of the Army (W911NF), where she plays a pivotal role in advancing the Army’s scientific and technical modernization priorities. She manages complex R&D acquisitions focused on disruptive technologies, autonomy, quantum systems, and intelligence horizon scanning, ensuring alignment with national defense innovation goals. Her portfolio centers on mission-critical contracts that bridge academic, industrial, and government research ecosystems, facilitating the transition of emerging technologies from lab to field. She specializes in non-commercial, performance-based acquisitions under FAR Part 35 and other specialized authorities to support high-risk, high-reward scientific endeavors. Julia cultivates strategic partnerships with a diverse array of research institutions, defense contractors, and specialized laboratories, primarily engaging firms with proven expertise in physical and engineering sciences. While no single contractor dominates her portfolio, she consistently collaborates with organizations capable of delivering scalable, classified, and dual-use solutions in advanced materials, sensor systems, and computational modeling. Her contracting approach emphasizes technical rigor, competitive transparency, and long-term collaboration over transactional vendor relationships, fostering innovation through structured performance metrics and milestone-based incentives. Julia’s procurement patterns reflect a strong preference for open competition, with 100% of her acquisitions classified as “No Set-Aside.” While she does not routinely utilize 8(a), HUBZone, or SDVOSB set-asides, she actively promotes small business participation through subcontracting opportunities and mentor-protégé programs embedded within larger R&D contracts. Her approach prioritizes capability over socioeconomic status, ensuring mission readiness while still encouraging broad industry engagement. Her primary procurement focus lies in NAICS 541712 and 541715, encompassing fundamental and applied research in physical, engineering, and life sciences—excluding biotechnology and nanotechnology. She also frequently procures pharmaceutical preparation manufacturing services under NAICS 325412, supporting medical countermeasures and battlefield health systems. Her technical domain expertise spans autonomous systems, quantum sensing, advanced diagnostics, and predictive analytics, making her a key conduit for translating scientific breakthroughs into operational Army capabilities.